Spark Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
37.57 M |
Public Float |
18.71 M |
Spark Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.36 |
Market Cap |
$3.89 B |
Shares Outstanding |
38.41 M |
Public Float |
34.81 M |
Address |
3737 Market Street Philadelphia Pennsylvania 19104 United States |
Employees | - |
Website | http://www.sparktx.com |
Updated | 07/08/2019 |
Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. |